SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

Search

Fagron

Geschlossen

BrancheGesundheitswesen

24.15 1.9

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

24.15

Max

24.15

Schlüsselkennzahlen

By Trading Economics

Einkommen

-99K

45M

Verkäufe

-98K

476M

KGV

Branchendurchschnitt

19.274

49.712

Dividendenrendite

1.64

Gewinnspanne

9.55

Angestellte

4,193

EBITDA

11M

98M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+20.59% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

1.64%

2.36%

Nächstes Ergebnis

30. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

123M

1.8B

Vorheriger Eröffnungskurs

22.25

Vorheriger Schlusskurs

24.15

Nachrichtenstimmung

By Acuity

50%

50%

129 / 342 Ranking in Healthcare

Fagron Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Über Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat